Strain differences in stress-induced changes in central CRF1 receptor expression

Neuroscience Letters

Volumn 561, Issue , 2014, Pages 192-197

  O'Malley, Dervla ^a,b   Julio Piepera, Marcela ^c   Dinan, Timothy G ^a,d   Cryan, John F ^a,d  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b Department of Physiology ^*  (Ireland)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE VALPARAÍSO   (Chile)

^d UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Anxiety; CRFR1; CRFR2; ERK MAPK; Stress; Wistar Kyoto

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE 1;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; COPING BEHAVIOR; FRONTAL CORTEX; HIPPOCAMPUS; HORMONE BINDING; HYPOTHALAMUS; LIGHT DARK CYCLE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; STRESS;

ANXIETY; CRFR1; CRFR2; ERK-MAPK; STRESS; WISTAR KYOTO;

AMYGDALA; ANIMALS; BRAIN; FRONTAL LOBE; HIPPOCAMPUS; HYPOTHALAMUS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; ORGAN SPECIFICITY; PHOSPHORYLATION; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SPECIES SPECIFICITY; STRESS, PSYCHOLOGICAL;

EID: 84892857626     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.12.065     Document Type: Article

References (33)

1. Bale T.L., Contarino A., Smith G.W., Chan R., Gold L.H., Sawchenko P.E., Koob G.F., Vale W.W., Lee K.F. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nature Genetics 2000, 24:410-414.
2. Bale T.L., Vale W.W. CRF and CRF receptors: role in stress responsivity and other behaviors. Annual Review of Pharmacology and Toxicology 2004, 44:525-557.
3. Bhatnagar S., Dallman M. Neuroanatomical basis for facilitation of hypothalamic-pituitary-adrenal responses to a novel stressor after chronic stress. Neuroscience 1998, 84:1025-1039.
4. Bravo J.A., Dinan T.G., Cryan J.F. Alterations in the central CRF system of two different rat models of comorbid depression and functional gastrointestinal disorders. The International Journal of Neuropsychopharmacology/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2010, 1-18.
5. Fales C.L., Barch D.M., Burgess G.C., Schaefer A., Mennin D.S., Gray J.R., Braver T.S. Anxiety and cognitive efficiency: differential modulation of transient and sustained neural activity during a working memory task. Cognitive, Affective & Behavioral Neuroscience 2008, 8:239-253.
6. Gibney S.M., Gosselin R.D., Dinan T.G., Cryan J.F. Colorectal distension-induced prefrontal cortex activation in the Wistar-Kyoto rat: implications for irritable bowel syndrome. Neuroscience 2010, 165:675-683.
7. Goodwin G.M. Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression. Journal of Psychopharmacology (Oxford, England) 1997, 11:115-122.
8. Greenwood-Van Meerveld B., Johnson A.C., Cochrane S., Schulkin J., Myers D.A. Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats. Neurogastroenterology and Motility: The Official Journal of the European Gastrointestinal Motility Society 2005, 17:415-422.
9. Herman J.P., Cullinan W.E. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends in Neurosciences 1997, 20:78-84.
10. Jacobson L., Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocrine Reviews 1991, 12:118-134.
11. Kostich W.A., Chen A., Sperle K., Largent B.L. Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor. Molecular Endocrinology (Baltimore, Md.) 1998, 12:1077-1085.
12. Nemeroff C.B. Early-life adversity, CRF dysregulation, and vulnerability to mood and anxiety disorders. Psychopharmacology Bulletin 2004, 38(Suppl. 1):14-20.
13. O'Mahony S.M., Marchesi J.R., Scully P., Codling C., Ceolho A.M., Quigley E.M., Cryan J.F., Dinan T.G. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biological Psychiatry 2009, 65:263-267.
14. O'Malley D., Dinan T.G., Cryan J.F. Alterations in colonic corticotropin-releasing factor receptors in the maternally separated rat model of irritable bowel syndrome: differential effects of acute psychological and physical stressors. Peptides 2010, 31:662-670.
15. O'Malley D., Dinan T.G., Cryan J.F. Neonatal maternal separation in the rat impacts on the stress responsivity of central corticotropin-releasing factor receptors in adulthood. Psychopharmacology 2011, 214:221-229.
16. O'Malley D., Julio-Pieper M., Gibney S.M., Dinan T.G., Cryan J.F. Distinct alterations in colonic morphology and physiology in two rat models of enhanced stress-induced anxiety- and depression-like behavior. Stress 2010, 13:114-122.
17. Primus R.J., Yevich E., Baltazar C., Gallager D.W. Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain. Neuropsychopharmacology 1997, 17:308-316.
18. Punn A., Levine M.A., Grammatopoulos D.K. Identification of signaling molecules mediating corticotropin-releasing hormone-R1alpha-mitogen-activated protein kinase (MAPK) interactions: the critical role of phosphatidylinositol 3-kinase in regulating ERK1/2 but not p38 MAPK activation. Molecular Endocrinology (Baltimore, Md.) 2006, 20:3179-3195.
19. Qi X., Lin W., Li J., Pan Y., Wang W. The depressive-like behaviors are correlated with decreased phosphorylation of mitogen-activated protein kinases in rat brain following chronic forced swim stress. Behavioural Brain Research 2006, 175:233-240.
20. Radulovic J., Ruhmann A., Liepold T., Spiess J. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 1999, 19:5016-5025.
21. Reyes B.A., Valentino R.J., Van Bockstaele E.J. Stress-induced intracellular trafficking of corticotropin-releasing factor receptors in rat locus coeruleus neurons. Endocrinology 2008, 149:122-130.
22. Rittenhouse P.A., Lopez-Rubalcava C., Stanwood G.D., Lucki I. Amplified behavioral and endocrine responses to forced swim stress in the Wistar-Kyoto rat. Psychoneuroendocrinology 2002, 27:303-318.
23. Sapolsky R.M. Stress, glucocorticoids, and damage to the nervous system: the current state of confusion. Stress (Amsterdam, Netherlands) 1996, 1:1-19.
24. Schulman D., Latchman D.S., Yellon D.M. Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway. American Journal of Physiology. Heart and Circulatory Physiology 2002, 283:H1481-H1488.
25. Shi F., Chiu Y.J., Cho Y., Bullard T.A., Sokabe M., Fujiwara K. Down-regulation of ERK but not MEK phosphorylation in cultured endothelial cells by repeated changes in cyclic stretch. Cardiovascular Research 2007, 73:813-822.
26. Slominski A., Zbytek B., Pisarchik A., Slominski R.M., Zmijewski M.A., Wortsman J. CRH functions as a growth factor/cytokine in the skin. Journal of Cellular Physiology 2006, 206:780-791.
27. Smith G.W., Aubry J.M., Dellu F., Contarino A., Bilezikjian L.M., Gold L.H., Chen R., Marchuk Y., Hauser C., Bentley C.A., Sawchenko P.E., Koob G.F., Vale W., Lee K.F. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 1998, 20:1093-1102.
28. Spencer S.J., Buller K.M., Day T.A. Medial prefrontal cortex control of the paraventricular hypothalamic nucleus response to psychological stress: possible role of the bed nucleus of the stria terminalis. The Journal of Comparative Neurology 2005, 481:363-376.
29. Steckler T., Dautzenberg F.M. Corticotropin-releasing factor receptor antagonists in affective disorders and drug dependence - an update. CNS & Neurological Disorders Drug Targets 2006, 5:147-165.
30. Van Pett K., Viau V., Bittencourt J.C., Chan R.K., Li H.Y., Arias C., Prins G.S., Perrin M., Vale W., Sawchenko P.E. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. The Journal of Comparative Neurology 2000, 428:191-212.
31. Wouters M.M., Van Wanrooy S., Casteels C., Nemethova A., de Vries A., Van Oudenhove L., Van den Wijngaard R.M., Van Laere K., Boeckxstaens G. Altered brain activation to colorectal distention in visceral hypersensitive maternal-separated rats. Neurogastroenterology and Motility: The Official Journal of the European Gastrointestinal Motility Society 2012, 24:678-685. e297.
32. Wu S.L., Hsu L.S., Tu W.T., Wang W.F., Huang Y.T., Pawlak C.R., Ho Y.J. Effects of d-cycloserine on the behavior and ERK activity in the amygdala: role of individual anxiety levels. Behavioural Brain Research 2008, 187:246-253.
33. Zorrilla E.P., Koob G.F. The therapeutic potential of CRF1 antagonists for anxiety. Expert Opinion on Investigational Drugs 2004, 13:799-828.